Skip to content
University of Colorado Anschutz Medical Campus CU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 

Tools & Resources

  • Events Calendar
  • Newsroom
  • Strauss Health Sciences Library
  • Department A-Z Directory
  • Campus Directory
  • Leadership
  • Faculty & Staff Resources
  • Supporter & Alumni Resources
  • Student Resources
  • Campus Map
  • University Policies
  • Give Now

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU System
  • CU Online

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

Biobank

Colorado Center for Personalized Medicine

  • Home
  • About
    • How It Works
    • FAQs
    • Newsletter
      • Newsletter Archive
  • Enrolled Participants
    • Updating Your Biobank Consent Form
    • Participant Profile
    • Partnerships
  • Return of Results
  • Providers
    • Providers FAQs
    • Results
      • PGX
        • Brivaracetam
        • Clobazam
        • Clobazam Tipsheet
        • Clopidogrel
        • DPYD
        • DPYD Tipsheet
        • PPIS
        • PPIS Tipsheets
          • Poor Metabolizers
          • Intermediate Metabolizers
          • Rapid Metabolizers
          • Ultrarapid Metabolizers
        • SSRIS
        • SSRIS Tipsheet
        • Statins
        • Statins Tipsheet Decreased
        • Statins Tipsheet Poor
        • Voriconazole
        • Voriconazole Tipsheet
    • Resources
  • Investigators & Partners
    • Resources
    • Translational Informatics Services (TIS)
      • CCPM biobank exploration services
      • Genetic data delivery services
      • Genetic data analysis services
      • Custom pipeline generation services
    • Access to Biobank Committee (ABC)
    • Application Process
    • FAQs
  • Withdraw Form
  • Contact Us
University Quick Links

Pharmacogenetic Results

Results that may predict response to medications. Information for healthcare professionals.

  • Home
  • Providers
  • Results
  • PGX

Overview of Pharmacogenetic Return of Results

Pharmacogenetics (PGx) is the use of genetic information to help guide drug selection and dosing.  

The Colorado Center for Personalized Medicine is enrolling participants in a research Biobank, primarily focused on genetics. 

Biobank participants may give permission to return available genetic test results, including select, clinically-actionable PGx test results to their UCHealth electronic health record (EHR). 

Genes in Focus

The Biobank is returning results for 3 pharmacogenetic (PGx) genes: CYP2C19, SLCO1B1 & DPYD.

Prerequisites for Return

In order for results to be available to providers, a Biobank participant must have a blood or saliva sample collected and processed and sign appropriate consent for return.  

Scroll down to see FAQs

PGx Exceptions

Click here to learn how liver transplant & allogeneic BMT impact PGx results. 
Screen Shot 2022-04-14 at 3.06.55 PM

Drug-Gene Pairs

Brivaracetam & CYP2C19
Clobazam & CYP2C19

 

Clopidogrel & CYP2C19
Fluoropyrimidines & DPYD
PPIs & CYP2C19
SSRIs & CYP2C19
Statins & SLCO1B1
Voriconazole & CYP2C19

Pharmacogenetic Tip Sheets

Brivaracetam Tip Sheet
Clobazam Tip Sheet
DPYD Tip Sheet
PPIs Tip Sheet
SSRIs Tip Sheet
Statins Tip Sheet: Decreased Function
Statins Tip Sheet: Poor Function
Voriconazole Tip Sheet

Biobank participants who have provided a sample for genotyping and consented to receive results may receive results if they are available. For pharmacogenetic results, participants will be notified via UCHealth's MyHealthConnection patient portal.  The date that these results file into the EHR is the date that the sample was initially collected, which may be several years before notification that results are now available.  If you or your patient is having a hard time finding their results, please scroll back several years in the EHR to identify Biobank results. 

No. However, CCPM has embedded clinical decision support (CDS) tools into UCHealth’s EHR to notify clinicians of gene-drug interactions at the time of prescribing. As of December 2021, clinical decision support is available for 17 drug-gene pairs affected by variation in CYP2C19 or SLCO1B1.

Please note that not all medications are metabolized by CYP2C19 or transported by SLCO1B1. For medications that are metabolized by CYP2C19, CYP2C19 genotype does not impact outcomes for all medications to the same extent, or does so in an indication-specific manner.  For medications that are transported by SLCO1B1, SLCO1B1 genotype does not impact outcomes for all medications to the same extent.

For further information, please visit the drug-gene specific resources and tip sheets below.  Additional information can be found on the UCHealth Provider Portal.

For general information about CYP2C19, click here.

For general information about SLCO1B1, click here.

The Colorado Center for Personalized Medicine (CCPM) is currently returning CYP2C19 & SLCO1B1 genotype results to Colorado Biobank participants. In order to receive a Biobank pharmacogenetic test result, a participant must sign a consent form agreeing that results can be placed in his or her electronic health record (EHR).  After this consent form is signed, results may then be placed into the participant’s EHR and sent to him or her via UCHealth’s MyHealthConnection patient portal (if results are available for the participant). Other pharmacogenetic test results will be released in a step-wise approach.  Please check back for updates.

An Important Note

The information you receive through this website is not intended to be medical advice.  The information you receive through this website will include genetic test results only.  If you need medical assistance, please seek care at an appropriate facility.  You should contact your doctor about any genetic test results that you receive from the Biobank.  Do not stop using or change any of your medicines before speaking with your doctor.

Colorado Center for Personalized Medicine

University of Colorado Anschutz Medical Campus

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Mailstop F563

Aurora, CO 80045


Contact Us
  • (303) 724-9944
  • CCPM-Biobank@ucdenver.edu
Study Title
  • Colorado Center for Personalized Medicine (CCPM) Biobank Research Study
COMIRB#
  • 15-0461 PI: Kristy Crooks, PhD, FACMG: Director, CCPM Biobank
  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2023 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window